연구성과로 돌아가기

2024 연구성과별 연구자 정보 (43 / 2344)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15) Sim, Sung Hoon Sim, SH 11 Natl Canc Ctr, Ctr Breast Canc, Goyang, South Korea oncolee@ewha.ac.kr;yhparkhmo@skku.edu;
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15) Lee, Keun Seok Lee, KS 12 Natl Canc Ctr, Ctr Breast Canc, Goyang, South Korea oncolee@ewha.ac.kr;yhparkhmo@skku.edu;
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15) Hyun Kim, Jee Kim, JH 13 Seoul Natl Univ, Seoul Natl Univ Coll Med, Dept Internal Med, Bundang Hosp, Seongnam, South Korea oncolee@ewha.ac.kr;yhparkhmo@skku.edu;
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15) Shim, Hyun-Jeong Shim, HJ 14 Chonnam Natl Univ, Dept Hematol Oncol, Med Sch, Gwangju, South Korea oncolee@ewha.ac.kr;yhparkhmo@skku.edu;
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15) Shim, Hyun-Jeong Shim, HJ 14 Hwasun Hosp, Gwangju, South Korea oncolee@ewha.ac.kr;yhparkhmo@skku.edu;
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15) Chae, Yeesoo Chae, Y 15 Kyungpook Natl Univ, Dept Internal Med, Chilgok Hosp, Daegu, South Korea oncolee@ewha.ac.kr;yhparkhmo@skku.edu;
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15) Koh, Su-Jin Koh, SJ 16 Ulsan Univ Hosp, Dept Hematol & Oncol, Ulsan, South Korea oncolee@ewha.ac.kr;yhparkhmo@skku.edu;
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15) Lee, Hyorak Lee, H 17 Korea Canc Ctr Hosp, Div Hematol Oncol, Seoul, South Korea oncolee@ewha.ac.kr;yhparkhmo@skku.edu;
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15) Lee, Jieun Lee, J 18 Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Med Oncol, Seoul, South Korea oncolee@ewha.ac.kr;yhparkhmo@skku.edu;
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15) Byun, Jae-Ho Byun, JH 19 Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Internal Med, Incheon, South Korea oncolee@ewha.ac.kr;yhparkhmo@skku.edu;
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15) Seol, Youngmi Seol, Y 20 Pusan Natl Univ Hosp, Dept Internal Med, Div Hematol & Oncol, Coll Med, Busan, South Korea oncolee@ewha.ac.kr;yhparkhmo@skku.edu;
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15) Lee, Eun Mi Lee, EM 21 Kosin Univ, Dept Internal Med, Gaspel Hosp, Busan, South Korea oncolee@ewha.ac.kr;yhparkhmo@skku.edu;
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15) Jee, Hee-Jung Jee, HJ 22 Korea Univ, Coll Med, Dept Biostat, Seoul, South Korea AAY-9026-2020 Jee, Hee-Jung oncolee@ewha.ac.kr;yhparkhmo@skku.edu;
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15) An, Hyonggin An, H 23 Korea Univ, Coll Med, Dept Biostat, Seoul, South Korea oncolee@ewha.ac.kr;yhparkhmo@skku.edu;
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15) Park, Eun Byeol Park, EB 24 Korea Univ, Coll Med, Dept Biostat, Seoul, South Korea 0009-0002-2339-1393 PARK, EUNBYEOL oncolee@ewha.ac.kr;yhparkhmo@skku.edu;
페이지 이동: